N/A
Completed N=31
MedActive: A Smartphone Intervention to Improve Adherence to Antipsychotic Medications
Source: ClinicalTrials.gov NCT01953237 ↗Enrolled (actual)
31
Serious AEs
0.0%
Results posted
Dec 2016
Primary outcomePrimary: Adherence to Antipsychotic Medications — 92.6; 93.4 percentage of days adherent — p=0.5580
Summary
We propose to develop and pilot test the effect of a mobile smartphone intervention, MedActive, on improving antipsychotic adherence among individuals with schizophrenia.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Adherence to Antipsychotic Medications |
92.6; 93.4 | 0.5580 |
Eligibility Criteria
Inclusion Criteria
- Decisional capacity to provide informed consent
- Chart diagnosis of schizophrenia or schizoaffective disorder
- Currently prescribed at least one oral antipsychotic medication
- Self administers at least one oral antipsychotic medication
- 18-64 years of age
- English Speaking
- Be able to read English
Exclusion Criteria
- Has visual, hearing, voice, or motor impairment that would prevent completion of study procedures or use of mobile phone
Data sourced from ClinicalTrials.gov (NCT01953237). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.